AF
NVO

Arrow Financial’s Novo Nordisk NVO Stock Holding History

Arrow Financial’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20
Closed -$2.38K – 275
2024
Q3 		$2.38K Hold
20
– – ﹤0.01% 321
2024
Q2 		$2.85K Hold
20
– – ﹤0.01% 316
2024
Q1 		$2.57K Buy
+20
New +$2.38K ﹤0.01% 314
2015
Q2 		– Sell
-176
Closed -$5K – 378
2015
Q1 		$5K Buy
+176
New +$4.05K ﹤0.01% 331

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Arrow Financial's NVO Position: Q4 2024 in Review

Arrow Financial sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 20 shares — an estimated $2.38K sold.

Arrow Financial first reported a position in NVO in Q1 2015 and held it in 4 quarters. The position peaked at $5K in Q1 2015. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Arrow Financial reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Arrow Financial sold 20 Novo Nordisk shares in Q4 2024, an estimated $2.38K.
  • Arrow Financial first reported a position in Novo Nordisk in Q1 2015 and held it in 4 quarters.
  • Arrow Financial's Novo Nordisk position peaked at $5K in Q1 2015.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.